PEPFAR Reauthorization on the Horizon
In this Think Global opinion piece, Jennifer Kates and Kellie Moss discuss what could happen if the United States’ signature initiative on global health is not reauthorized.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
In this Think Global opinion piece, Jennifer Kates and Kellie Moss discuss what could happen if the United States’ signature initiative on global health is not reauthorized.
Based on analysis of PEPFAR data, this data note presents an overview of who PEPFAR served in 2022, looking at gender, age, and other characteristics.
As Congress considers reauthorizing the President’s Emergency Plan for AIDS Relief (PEPFAR) for a fourth time, a new KFF Policy Watch details key facts about the program and top issues related to its authorization and funding.
This year, Congress will consider reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR). This Policy Watch provides fast facts about the program and top issues related to its authorization and funding.
Jennifer Kates, Senior Vice President and Director of KFF’s Global Health & HIV Policy program, testified before the U.S. House of Representatives’ Committee on Foreign Affairs as part of a hearing on Unique Challenges Women Face in Global Health. Her testimony describes the role of the U.S. government in women’s global health and highlights challenges and opportunities to strengthen these efforts.
With ongoing questions about future U.S. support for multilateral health efforts as well as important markers on the near horizon, including donor replenishment conferences for both the Global Fund and Gavi within the next two years, this brief highlights five key facts about U.S. engagement with multilateral global health organizations.
The potential for the COVID-19 pandemic to significantly affect the health and development of low- and middle-income countries (LMICs), particularly those in sub-Saharan Africa, has serious implications for PEPFAR, the President’s Emergency Plan for AIDS Relief (PEPFAR). This issue brief examines the steps PEPFAR has taken to respond to the outbreak and the issues at stake.
Women and girls represent more than half of all people living with HIV worldwide, and HIV is the leading cause of death among women aged 15-49. This analysis sought to quantify PEPFAR’s role for women and girls in key program areas, analyzing data over time as well as by country, to better understand the extent of its reach.
In this Policy Insight, Jen Kates and Josh Michaud look at the prospects for the future of U.S. global health policy, examining whether long-term bipartisan support may be tested during a time of political transition, and identifying key areas of consensus among policymakers and the public.
After Congress provided an unprecedented level of emergency funding for Ebola in FY15 in response to the West African outbreak, beyond regular appropriations for global health programs, FY16 returned to business as usual. There was no additional emergency funding and global health amounts remained essentially flat funding compared to prior years. The FY16 Omnibus Appropriations bill, which was signed into law by the President on December 18, 2015, included an estimated $10.2 billion in funding for global health programs continuing a trend of essentially flat funding since FY10.
© 2025 KFF